‘We’re investing in AI the cheaper way’: 3i Infrastructure’s James Dawes
Infrastructure lies at the very heart of the AI opportunity. There is no Claude or ChatGPT without data centres or power. But how can invest...
Radio and PodcastLive Radio & Podcasts
Business
Investors Chronicle
Concerned with QE's effects on equity valuations? Looking for ideas for your Isa? Or just plain confused by the stock market? Each week, the Investors Chronicle picks apart the latest news f...
Episodes
20 of 1,186 episodes
Are the biggest Aim stocks also the best: Companies and Markets Show
This week, we return to our ultimate guide to Britain’s junior market, as we mark the release of Part Two of our Aim 100 Special Report. We...
Profiting from warnings, asset managers and Johnson & Johnson: Companies and Markets Show
Third-quarter earnings season (Q3) is under way and it’s taking place amid some renewed wobbles for AI and chip stocks. With this in mind, t...
The best Aim stocks and safe investment trusts: Companies and Markets show
This week’s episode marks the publication of the first half of our annual Aim 100 special report – our review of the biggest companies tradi...
Future-proofing portfolios, a new Help to Buy and takeovers: Companies and Markets show
This week’s episode begins by looking into Labour’s new ‘Your First Home’ scheme, a replacement for the controversial Help to Buy programme....
Meeting Pebble Beach's CEO: Lee & The IC
Lord John Lee and Alex Newman are back on the mics to get into the nitty-gritty of small-cap stocks, looking at software provider Pebble Bea...
British AI winners, prize draws and perfect pensions: Companies and Markets Show
This week’s episode kicks off with the latest batch of London-listed AI players. Up first are the IT resellers who are reaping the rewards o...
'Pessimists sound smart, but optimists make money'— Richard Clode on AI, risk and finding growth
The Bankers Investment Trust is a global stock market fund with around £1.5bn in assets. It’s an exciting time for the trust as it says good...
McBride, Supermarket Income Reit and AI threats
This week’s episode looks at two companies making a series of deals and partnerships in a bid to buck the troubling trends in their respecti...
Back to basics: How to build a portfolio
Figuring out which funds to buy is overwhelming for even the most experienced investors – but as a beginner, it’s important to understand yo...
Semiconductor stocks, our Top 50 Funds and Mortgage Advice Bureau: Companies and Markets Show
Even as uncertainty reins in the markets, 2026 has been another bumper year for returns. But, as ever, that does hide plenty of dispersion b...
Our favourite ETFs, toxic stocks to avoid and industrials: Companies and Markets show
This week’s show begins with a look at Meta after the social media giant had to fork out $18bn following accusations that its products are d...
Protecting your pension, UK industrials and Nvidia: Companies and Markets Show
First, we cast our ears to British industrial stocks and ask whether they are being picked off too cheaply. Michael Fahy dives into why manu...
How to invest under Andy Burnham: Lee and the IC
After a summer hiatus, Alex Newman and Lord Lee are back in the studio, and the duo have a lot to catch up on. The UK has seen a change of p...
JD Sports, Pershing Square’s overhaul and Oxford Nanopore:Companies and Markets Show
Up first this week is self-labelled ‘King of Trainers’ JD Sports, whose shares took a 15 per cent tumble on Thursday morning. The FTSE 100 r...
Legal & General, infrastructure stocks and GSK: Companies and Markets Show
After an avalanche of earnings updates, we turn to our annual Income Majors special report and dive into two prominent FTSE 100 dividend sto...
How to defeat the gender wealth gap
Women, on average, earn less than men, have less saved in a pension and have to take more time off from work to care for others. But while s...
The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show
M&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US r...
US IPOs, Rentokil and emerging markets: Companies and Markets show
Results season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards,...
‘We are the space 3i’: Mark Boggett of Seraphim Space
Seraphim Space (SSIT) has been one of the best performing investment trusts in the past year. Helped by the enthusiasm for the sector genera...